February 24, 2022 01:00 PM EST
Pharma
Manufacturing

On a roll, Re­ci­pharm wraps up its sec­ond and third CD­MO ac­qui­si­tions this month

Josh Sullivan

Re­ci­pharm is end­ing the month of Feb­ru­ary the same way it start­ed: with an ac­qui­si­tion. Two of them, to be pre­cise.

The Swedish com­pa­ny will …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

SEC probe of Il­lu­mi­na’s Grail deal tar­gets sales fore­casts, sources say

House pass­es Biose­cure Act, send­ing Chi­nese biotech ban to Sen­ate

Bris­tol My­ers touts LAG-3 strat­e­gy in lung can­cer as it preps for show­down with Mer­ck’s Keytru­da

Ar­bor Biotech­nolo­gies cuts ear­ly-stage dis­cov­ery work, lays off staff

Pfiz­er tees up Phase 3 test in weight man­age­ment — but in an un­ex­pect­ed area

FDA ap­proves sub­cu­ta­neous Ocre­vus, broad­en­ing ac­cess to Roche and Genen­tech block­buster

A service from the Financial Times